Pasi Kankaanpaa

Title: **Pasi Kankaanpaa: Innovator in Neonatal Hemoglobin Screening**

Introduction:

Pasi Kankaanpaa, an esteemed inventor based in Parainen, Finland, has significantly contributed to the field of neonatal screening. His innovative work addresses critical health issues concerning hemoglobinopathies in newborns through the development of a precise assay.

Latest Patents:

Kankaanpaa holds a patent for his invention titled "Hemoglobin assay for neonatal screening." This groundbreaking assay is designed to quantitatively determine the presence of at least one pair of hemoglobin (Hb) variants in newborns. By analyzing the ratio between the signals obtained from each variant, the assay can effectively determine whether the tested subject is afflicted by a hemoglobinopathy.

Career Highlights:

Pasi Kankaanpaa is associated with Wallac Oy, where he continues to apply his expertise in the realm of medical diagnostics. His dedication to innovation has led to advancements that improve early detection and treatment of hemoglobin disorders.

Collaborations:

Throughout his career, Kankaanpaa has collaborated with talented colleagues, including Kaj Blomberg and Thomas Campbell. These partnerships have fostered a collaborative environment that encourages the exchange of innovative ideas and solutions within the realm of medical technology.

Conclusion:

Pasi Kankaanpaa's contributions to neonatal screening demonstrate his commitment to improving healthcare outcomes for newborns. His patent for the hemoglobin assay marks a significant advancement in the medical field, showcasing the importance of innovation in diagnosing and managing health conditions early in life.